Preparing for the NASH Epidemic: A Call to Action-Reference-Cited by-同舟云学术

Preparing for the NASH Epidemic: A Call to Action

Published:2021-09 Issue:3 Volume:161 Page:1030-1042.e8
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Kanwal Fasiha,Shubrook Jay H.,Younossi Zobair,Natarajan Yamini,Bugianesi Elisabetta,Rinella Mary E.,Harrison Stephen A.,Mantzoros Christos,Pfotenhauer Kim,Klein Samuel,Eckel Robert H.,Kruger Davida,El-Serag Hashem,Cusi Kenneth

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference86 articles.

1. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of nonalcoholic fatty liver disease;Paik;Hepatology,2020

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes;Wong;Clin Liver Dis (Hoboken),2018

4. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease;Younossi;Hepatol Commun,2017

5. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIR8 protects against nonalcoholic steatohepatitis by antagonizing lipotoxicity-induced PPARα downregulation and reducing the sensitivity of hepatocytes to LPS;Translational Research;2024-10

2. Tanshinone IIA Inhibits the Endoplasmic Reticulum Stress-Induced Unfolded Protein Response by Activating the PPARα/FGF21 Axis to Ameliorate Nonalcoholic Steatohepatitis;Antioxidants;2024-08-23

3. The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH;Scientific Reports;2024-07-26

4. SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives;Cancers;2024-07-18

5. Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH;Hepatology Communications;2024-06-27